We can now see further evidence that near infrared light stimulation can positively influence beta amyloid production and this can have a significant impact on people with cognitive decline from neurodegenerative Alzheimer's and Parkinson's disease.
Quietmind Fdn. is using these technologies in our current clinical trials. Call 610-940-0488 for details.
Our team regularly publishes articles and blog posts on the latest research and news coming out of our group and the field in general.
Monday & Thursday: 11am - 6pm
remote conferencing available
Main Office- PA
8120 Old York Road, Suite 140
Elkins Park, PA 19027
New York Office
1619 3rd Ave. Suite 202 New York, NY 10128
(clinical trial evaluation only)
QuietMIND Foundation is a 501c3 charitable nonprofit. Donations are fully tax deductible. We work to provide services regardless of ability to pay, please help those who need help.